Dauricine induces apoptosis, inhibits proliferation and invasion through inhibiting NF-κB signaling pathway in colon cancer cells

Journal of Cellular Physiology

Volumn 225, Issue 1, 2010, Pages 266-275

  Yang, Zhengfeng ^a   Li, Chenghai ^a   Wang, Xiu ^a   Zhai, Chunyan ^a   Yi, Zhengfang ^a   Wang, Lei ^a   Liu, Bisheng ^a   Du, Bing ^a   Wu, Huihui ^a   Guo, Xizhi ^b   Liu, Mingyao ^a   Li, Dali ^a   Luo, Jian ^a  

^a EAST CHINA NORMAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLOOXYGENASE 2; DAURICINE; GELATINASE B; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 1; INTERCELLULAR ADHESION MOLECULE 1; MYC PROTEIN; PROTEIN BCL 2; SURVIVIN; SYNAPTOTAGMIN I; VASCULOTROPIN; X LINKED INHIBITOR OF APOPTOSIS;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL INVASION; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG INHIBITION; GENE EXPRESSION PROFILING; GROWTH INHIBITION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSLOCATION LINE; TUMOR GROWTH;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; BENZYLISOQUINOLINES; CASPASES; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; I-KAPPA B PROTEINS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE 9; MOLECULAR STRUCTURE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; POLY(ADP-RIBOSE) POLYMERASES; SIGNAL TRANSDUCTION; TETRAHYDROISOQUINOLINES;

MENISPERMUM;

EID: 77956501287     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22261     Document Type: Article

References (37)

1. Carpizo DR, D'Angelica M. 2009. Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease. Lancet Oncol 10:801-809.
2. Collins I, Workman P. 2006. New approaches to molecular cancer therapeutics. Nat Chem Biol 2:689-700. (Pubitemid 44764211)
3. Cragg GM, Grothaus PG, Newman DJ. 2009. Impact of natural products on developing new anti-cancer agents. Chem Rev 109:3012-3043.
4. Du ZH, Liu HG, Chai CY, Luo LY, Hu CJ. 1986. Anti-inflammatory effect of dauricine. Zhongguo Yao Li Xue Bao 7:419-422.
5. Fantini MC, Pallone F. 2008. Cytokines: From gut inflammation to colorectal cancer. Curr Drug Targets 9:375-380.
6. Fu XX. 1991. Therapeutic effect of combined treatment with Ara-A dauricine and Chinese herbs in chronic hepatitis B infection. Zhonghua Nei Ke Za Zhi 30:498-501. 522.
7. Guo DL, Zhou ZN, Zeng FD, Hu CJ. 1997. Dauricine inhibited L-type calcium current in single cardiomyocyte of guinea pig. Zhongguo Yao Li Xue Bao 18:419-421.
8. Hamid T, Gu Y, Ortines RV, Bhattacharya C, Wang G, Xuan YT, Prabhu SD. 2009. Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: Role of nuclear factor-kappaB and inflammatory activation. Circulation 119:1386-1397.
9. He L, Liu GQ. 2002. Interaction of multidrug resistance reversal agents with P-glycoprotein ATPase activity on blood-brain barrier. Acta Pharmacol Sin 23:423-429. (Pubitemid 34467969)
10. He QY, Meng FH, Zhang HQ. 1996. Reduction of doxorubicin resistance by tetrandrine and dauricine in harringtonine-resistant human leukemia (HL60) cells. Zhongguo Yao Li Xue Bao 17:179-181.
11. Hu ZY, Chen SL, Hao ZG, Huang WL, Peng SX. 1989. Benzylisoquinoline compounds inhibit the ability of calmodulin to activate cyclic nucleotide phosphodiesterase. Cell Signal 1:181-185.
12. Jemal A, Siegel R, Ward E, Hao YP, Xu JQ, Thun MJ. 2009. Cancer Statistics, 2009. CA Cancer J Clin 59:225-249.
13. Karin M. 2006. Nuclear factor-kappaB in cancer development and progression. Nature 441:431-436.
14. Karin M, Cao Y, Greten FR, Li ZW. 2002. NF-kappaB in cancer: From innocent bystander to major culprit. Nat Rev Cancer 2:301-310.
15. Kong XY, Gong PL. 2005. Effect of phenolic alkaloids of Menispermum dauricum on thrombosis and platelet aggregation. Yao Xue Xue Bao 40:916-919.
16. Kumar A, Takada Y, Boriek AM, Aggarwal BB. 2004. Nuclear factor-kappaB: Its role in health and disease. J Mol Med 82:434-448. (Pubitemid 39044283)
17. Lai JH, Ho LJ, Kwan CY, Chang DM, Lee TC. 1999. Plant alkaloid tetrandrine and its analog block CD28-costimulated activities of human peripheral blood T cells: Potential immunosuppressants in transplantation immunology. Transplantation 68:1383-1392.
18. Lee UJ, Choung SR, Prakash KV, Lee EJ, Lee MY, Kim YJ, Han CW, Choi YC. 2008. Dual knockdown of p65 and p50 subunits of NF-kappaB by siRNA inhibits the induction of inflammatory cytokines and significantly enhance apoptosis in human primary synoviocytes treated with tumor necrosis factor-alpha. Mol Biol Rep 35:291-298.
19. Li SN, Zhang KY. 1992. Effects of dauricine on action potentials and slow inward currents of guinea pig ventricular papillary muscles. Zhongguo Yao Li Xue Bao 13:535-537.
20. Li C, Yang Z, Zhai C, Qiu W, Li D, Yi Z, Wang L, Tang J, Qian M, Luo J, Liu M. 2010. Maslinic acid potentiates the anti-tumor activity of tumor necrosis factor alpha by inhibiting NFkappaB signaling pathway. Mol Cancer 9: 73.
21. Lloyd SC, Harvey NR, Hebert JR. 2007. Racial disparities in colon cancer: Primary care endoscopy as a tool to increase screening rates among minority patients (vol. 109, 378, 2007). Cancer 109:2154-2154.
22. Pang X, Yi T, Yi Z, Cho SG, Qu W, Pinkaew D, Fujise K, Liu M. 2009. Morelloflavone, a biflavonoid, inhibits tumor angiogenesis by targeting rho GTPases and extracellular signal-regulated kinase signaling pathways. Cancer Res 69:518-525.
23. Pearson JR, Gill CIR, Rowland IR. 2009. Diet, fecalwater, and colon cancer - development of a biomarker. Nutr Rev 67:509-526.
24. Qian JQ. 2002. Cardiovascular pharmacological effects of bisbenzylisoquinoline alkaloid derivatives. Acta Pharmacol Sin 23:1086-1092.
25. Sclabas GM, Uwagawa T, Schmidt C, Hess KR, Evans DB, Abbruzzese JL, Chiao PJ. 2005. Nuclear factor kappa B activation is a potential target for preventing pancreatic carcinoma by aspirin. Cancer 103:2485-2490.
26. Sung B, Pandey MK, Ahn KS, Yi T, Chaturvedi MM, Liu M, Aggarwal BB. 2008. Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-kappaB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-kappaBalpha kinase, leading to potentiation of apoptosis. Blood 111:4880-4891.
27. Wagner EF, Nebreda AR. 2009. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9:537-549.
28. Wang Y, Zhong D, Chen X, Zheng J. 2009. Identification of quinone methide metabolites of dauricine in human liver microsomes and in rat bile. Chem Res Toxicol 22:824-834.
29. Wu YJ, Fang DC. 1992. Quantitative studies on dauricine block of cardiac sodium channels. Zhongguo Yao Li Xue Bao 13:55-58.
30. Xia JS, Tu H, Li Z, Zeng FD. 1999. Dauricine suppressed CsCl-induced early after depolarizations and triggered arrhythmias in rabbit heart in vivo. Zhongguo Yao Li Xue Bao 20:513-516.
31. Xia JS, Guo DL, Zhang Y, Zhou ZN, Zeng FD, Hu CJ. 2000. Inhibitory effects of dauricine on potassium currents in guinea pig ventricular myocytes. Acta Pharmacol Sin 21:60-64. (Pubitemid 30051444)
32. Xia JS, Li Z, Dong JW, Tu H, Zeng FD. 2002. Dauricine-induced changes in monophasic action potentials and effective refractory period of rabbit left ventricle in situ. Acta Pharmacol Sin 23:371-375.
33. Yang XY, Jiang SQ, Zhang L, Liu QN, Gong PL. 2007. Inhibitory effect of dauricine on inflammatory process following focal cerebral ischemia/reperfusion in rats. Am J Chin Med 35:477-486.
34. Zeng GQ, Ju DW, Sun DX, Rui YC. 1993. Dauricine and anisodamine inhibited leukotrienes- and platelet activating factor-induced DNA synthesis and proliferation of bovine cerebral microvascular smooth muscle cells in culture. Zhongguo Yao Li Xue Bao 14:329-331.
35. Zhang Y, Liu D, Li Y. 1998. Effect of dauricine on redistribution of glycoprotein IV in platelet membrane of patients with mitral stenosis. Zhongguo Zhong Xi Yi Jie He Za Zhi 18:461-463.
36. Zhou JA, Fang WY, Wang C, Zhou JL, Guan HP. 1987. The effects of dauricine and verapamil as calcium channel blockers on the plasma concentration of 6-keto-prostaglandin F1 alpha and thromboxane B2 during cardiopulmonary bypass. Thorac Cardiovasc Surg 35:172-175. (Pubitemid 17096506)
37. Zhu JQ, Zeng FD, Hu CJ. 1992. Protective and anti-arrhythmic effects of dauricine and verapamil on acute myocardial infarction in anesthetized dogs. Zhongguo Yao Li Xue Bao 13:249-251.